This will be a rapid-fire session with 5 minute presentations on a spectrum of challenges for the single ventricle patient.

*Unless otherwise noted, speakers have nothing to disclose.

Moderators

Iki Adachi (Commercial Relationships: Abbott: Consultant Advisory/Board; Jarvik Inc., Consultant Advisory/Board; Medtronic; Consultant Advisory/Board)

David Morales (Commercial Relationships: Abbott, Consultant Advisory/Board, Speaker Honoraria; Azyio, Consultant Advisory/Board; Berlin Heart, Consultant Advisory/Board; Medtronic, Consultant Advisory/Board; SynCardia, Consultant Advisory/Board)

Presentations:

1. High Risk Status for Stage 1 Palliation in Single Ventricle Pathology Leads to Increased Risk of Mortality and Re-Admission Following Stage II But Not Stage III Palliation - Garrett Coyan

(Commercial Relationships: Neoolife; Ownership interest, Non-remunerative positions of influence, such as officer, board member, trustee or public spokesperson)

2. Peripheral Pulmonary Artery Stenosis is Not a Contraindication to the Single Ventricle Pathway - Abdulaziz Alkhaldi

(Commercial Relationships: Medtronic; Consultant Advisory/Board)

3. Outcomes of One-and-one-half Ventricle Repair Patients: Role for Separation of the Glenn and Antegrade Pulmonary Blood Flow? - Anagha Prasanna

4. Evolution of Ventricular Assist Device Support Strategies in 18 Consecutive Children with Single Ventricle Physiology: A Single Center Experience - Taylor Merritt

5. Hybrid Procedure combined with Ventricular Assist Device (VAD) insertion: Experience with 9 High Risk Neonates and Infants with Hypoplastic Left Heart Syndrome (HLHS) - Mark Bleiweis

6. The STS Public Reporting System of Congenital Heart Surgery Outcomes May not be Useful to Guide Referrals for Practicing Pediatric Cardiac Providers - Nicholas Schreiter